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Abstract
Disease-modifying treatments are currently assessed in
neurodegenerative diseases. Huntington’s Disease represents
a unique opportunity to design automatic sub-clinical markers,
even in premanifest gene carriers. We investigated phonatory
impairments as potential clinical markers and propose them for
both diagnosis and gene carriers follow-up. We used two sets of
features: Phonatory features and Modulation Power Spectrum
Features. We found that phonation is not sufficient for the iden-
tification of sub-clinical disorders of premanifest gene carriers.
According to our regression results, Phonatory features are suit-
able for the predictions of clinical performance in Huntington’s
Disease.
Index Terms: Huntington’s disease, Phonation, Pathological
speech processing, Dysarthria, Modulation Power Spectrum.
1. Introduction
Huntington’s disease is an autosomal dominant neurodegener-
ative disease with a complete penetrance [1]. The disease is
characterised by a triad of symptoms (motor, cognitive and psy-
chiatric [2]) that leads to the progressive disability functioning
of the individual with HD. The age of the clinical onset is highly
variable (mean around 45 year-old) and the symptoms gradu-
ally worsen over 15 to 20 years until the death. The motor
assessment allows defining a cut-off score that splits between
premanifest and manifest gene carriers and thus the disease on-
set. Therefore, some of the deficits cognitive or psychiatric im-
pairments or sub-clinical disorders may appear long before the
disease manifests.
The automatic identification of pre-symptomatic carriers of
the gene of Huntington’s Disease and the prediction of the clini-
cal scores are of particular interest for the neurological practice
[3]. Indeed, having ecological markers of these clinical end-
points may: (1) help to prevent detrimental and harmful life
events, (2) speed-up clinical trials, (3) increase the understand-
ing of the disease in ground truth condition. Here, by using
speech analysis of sustained phonation, we aim at distinguish-
ing, in individuals, stage of the disease and predicting their clin-
ical scores, as assessed by neurologists and neuropsychologists.
We rely on the fact that individuals with Huntington’s
Disease can exhibit different disorders during speech [4, 5]
and language production [6, 7]. Motor speech disorders in
Huntington’s Disease are commonly referred to as hyperkinetic
dysarthria [8]: variable rate, abnormal prosody, imprecise con-
sonants and distorted vowels, phonation deviations, and sudden
forced breath. Yet, there is some recent evidence that the speech
motor impairments in Huntington’s Disease are highly hetero-
geneous [9].
Here, we considered the speech features collected from
simple recordings of the French vowel /a/ uttered in a sustained
manner for as long as possible, in regular clinical conditions.
We collected production of these vowels for Healthy Controls
(C), gene carriers without overt manifestation of Huntington’s
Disease (preHD) and manifest gene carriers of Huntington’s
Disease (HD). We modelled each vowel with several features,
which are impaired in hyperkinetic dysarthria. We investigated
two sets of features: (1) Phonatory features already proven use-
ful to distinguish gene carriers from control (preHD vs Controls
[4] and HD vs Controls [10]), (2) Modulation Power Spectrum
features to measure the modulations that characterise speech in-
telligibility [11] and roughness [12]. First, we conducted a sta-
tistical analysis at the group level of these features. Then, based
on these sets of features, we used regularised linear models to
predict the group and clinical scores of the patients.
Our statistical analyses and classification results showed
that HD patients distinguished from controls, whereas the
boundaries around preHD are more blurred. The Modulation
Power Spectrum features complemented the Phonatory features
to help identify preHD and improve the F1-score. In contrast,
we observed that the Phonatory features have the best predictive
capabilities of the clinical scores.
2. Related work
Previous studies have used sustained phonation for the assess-
ment of various neurodegenerative disorders such as Parkin-
son’s disease [13], Amyotrophic Lateral Sclerosis [14] and also
Huntington’s Disease [10]. These studies have extracted a num-
ber of hand-crafted features from the sustained phonation and
built discriminative models to distinguish patients from con-
trols. Yet, collecting pre-symptomatic speech data on other ac-
quired neurodegenerative diseases is difficult, and can only be
done retrospectively [15].
Rusz et al. [4] provided the closest study to ours using
Table 1: Participants demographics and clinical scores
Controls Huntington’s disease
Gene carriers
Sub-groups C PreHD HD
N 24 16 45
Gender 12F/12M 9F/7M 27F/18M
Age (years) 45.11 (8.93) 50.2 (12.2) 53.9 (11.3)
CAG Triplets ≤ 35 41.4 (1.5) 44.3 (3.4)
cUHDRS [16] — 17.6 (1.4) 9.0 (3.6)
TFC [17] — 13.0 (0.0) 10.3 (2.2)
TMS — 0.38 (1.0) 36.0 (15.9)
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sustained phonation for the automatic identification of preHD.
They show great discriminative performance between preHD
and controls.
Perez et al. [18] trained a Speech Recognition system on
Huntington’s speech and extracted a number of language fea-
tures ranging from speech rate, and goodness of pronunciation
to utterance length. The goal of this study differed from ours
as they grouped together the preHD and HD patients in a single
group to distinguish from control. They also pointed out to the
difficulty to identify preHD.
We did not find any study attempting to predict the clinical
scores in Huntington’s disease from speech. Our strategy, which
may allow following up individuals remotely, is likely to apply
to other neurodegenerative diseases, such as in the Parkinson’s
Disease [19] or Alzheimer Disease [20].
3. Voice Database
Eighty five participants were included from two observational
cohorts (NCT01412125 and NCT03119246) in this ancillary
study at the Hospital Henri-Mondor Créteil, France): 61 people
tested with a number of CAG repeats on the Huntingtin gene
above 35 [1] (CAG > 35), and 24 Healthy Controls (C) (See
Table 1). All participants signed an informed consent. Mutant
Huntingtin gene carriers were considered premanifest if both
they score less than five at the Total Motor score (TMS) and
their Total functional capacity (TFC) equals 13 [21] using the
Unified Huntington Disease Rating Scale (UHDRS) [22].
All participants completed a standardised speech battery.
The data were annotated with Seshat [23] and Praat [24] soft-
wares. The annotators were second-year graduate students in
speech pathology, all French native speakers.
Each participant was asked to take a deep breath and to sus-
tain the vowel /a/ at a constant intensity and pitch level for as
long as possible. The recordings were done in the same condi-
tion for all participants, with a ZOOM H4n Pro recorder, sam-
pled at 44.1 kHz with a 16-bit resolution.
Table 2: List of Phonatory features based on [4]. SD stands
for Standard Deviation. †The vocal tremor features could not be
computed on all samples.
Dimension Features
Airflow insufficiency Maximum Phonation Time
First Occurrence of Voice Break
Aperiodicity Number of Voice Breaks
Degree of Pitch Breaks
Degree of Vocal Arrests
Irregular vibration F0 SD
of vocal folds Recurrence Period Density Entropy
Signal perturbation Jitter (local)
Shimmer (local)
Increased noise Harmonics to Noise Ratio
Detrended Fluctuation Analysis
Vocal tremor† Frequency Tremor Intensity Index
Amplitude Tremor Intensity Index
Articulatory deficiency Mean of SD of MFCC
Mean of SD of Delta MFCC
4. Features
4.1. Phonatory Features
We used the Phonatory features from [10, 4] to measure dimen-
sions that can impede the correct sustained production of the
vowel /a/ for HD and preHD gene carriers: airflow insufficiency,
aperiodicity, irregular vibration of vocal folds, signal pertur-
bation, increased noise, vocal tremor, articulatory deficiency.
These features are summarised in the Table 2.
To automatically extract these features, we used the Praat
software [24], the Parselmouth wrapper [25] and the tremor
package [26]. The fundamental frequency (F0) and MFCCs
were obtained with the Kaldi toolkit [27]. Besides, we imple-
mented the Detrended Fluctuation Analysis and the Recurrence
Period Density Entropy features from [13], in Python. To com-
pute these two features and replicate [13], we down-sampled the
audio to 22.5 kHz, otherwise the audio is down-sampled to 16
kHz. Due to instability for the extraction of the tremor features,
there are missing data points for this dimension (See Table 3).
To overcome the limitations of heterogeneity of acoustic
methodologies across studies and libraries, we provide an open-
source version of the code (link) to reproduce our results and to
extract each dimension of the sustained phonation of the vowel
/a/.
4.2. Modulation Power Spectrum features
To complete the Phonatory features, we used the Modulation
Power Spectrum (MPS) extracted for each vowel /a/ of each in-
dividual. Different perceptual attributes occupy distinct areas
of the MPS: roughness, gender and size characteristics of the
speaker, and linguistic meaning [12]. Besides, the MPS cap-
tures the spectral and amplitude modulations of the pitch and its
harmonics. 1. The MPS representation is the amplitude spec-
trum of the 2D Fourier Transform of a time-frequency represen-
tation obtained from the sound waveform [11, 28]. This time-
frequency representation is a log-scaled amplitude of a spec-
trogram computed every 1 millisecond (ms) with a spacing be-
tween each frequency bin of 50Hz using a Gaussian window.
The linear spacing in the frequency axis [11] better describes
sounds that have harmonic structure, like long steady vowels.
The MPS is computed every 10 ms with a 100 ms window of
the spectrogram, then the final representation is averaged over
the full duration of the sound. Upward and downward tempo-
ral modulations are kept between -200 Hz and +200 Hz, and
spectral modulations between 0 and 9.5 Cycles/kHz (99% of
the energy was found between these intervals).
5. Methods
5.1. Group level: Statistical analysis
We followed the process for statistical comparison and correc-
tion from Rusz et al., 2014 [4]. Given the non-normality of the
data, we tested the differences between groups with the non-
parametric Kruskal-Wallis test. The Bonferroni correction is
applied to correct for the seven types of speech deficits (see
Table 2). For post-hoc analyses, we applied the Kolmogorov-
Smirnov test to all features to check for normality within each
group, and the Levene’s test for homoscedasticity between
groups. If normality and homoscedasticity requirements were
full-filled, we applied an independent t-test otherwise; we ap-
plied a non-parametric equivalent (Mann-Whitney U-test). The
p-values were Bonferroni corrected for multiple comparisons
per feature. We also estimated the effect size with the Cohen’s
d. Results are summarised in Table 3. Statistical analyses for
the MPS features are displayed in the arxiv version of this paper.
1Readers can refer to [11, 12] for in-depth study of the different
perceptual areas
Table 3: Results of the statistical analyses between the three groups for the sustain of the vowel /a/: Controls (C), asymptomatic genetic
carrier of Huntington’s Disease (preHD), symptomatic genetic carrier of Huntington’s Disease (HD). The p-values significativiy of the
tests (Kruskal-Wallis tests H-statistic (H stat) and post-hoc pairwise tests on the Cohen’s d) are reported with *: 0.01 < p ≤ 0.05,
**: 0.001 < p ≤ 0.01, ***: p ≤ 0.001. The post-hoc statistics are corrected for multiple comparison feature wise. SD stands for
standard deviation. † 23 HD, 6 preHD, 6 Controls data points could not be computed for the Frequency Tremor Intensity Index. ‡ 15
HD, 6 preHD, 3 Controls data points could not be computed for the Amplitude Tremor Intensity Index.
Mean (SD) H stat Effect size Cohen’s d
C preHD HD HD/PreHD HD/C preHD/C
Phonatory Features
Maximum Phonation Time (s) 17.0 (8.7) 15.7 (4.9) 9.1 (5.1) 23.6∗∗∗ -1.27∗∗∗ -1.19∗∗∗ -0.18
First Occurrence of Voice Break (s) 13.2 (7.6) 10.3 (5.7) 6.3 (5.1) 16.6∗∗∗ -0.77∗∗ -1.14∗∗∗ -0.41
Number of Voice Breaks 3.6 (9.2) 7.2 (12.3) 3.8 (7.4) 2.9 -0.37 0.02 0.34
Degree of Pitch Breaks (%) 1.1 (3.1) 4.8 (9.4) 6.3 (10.6) 5.7 0.15 0.59∗∗ 0.59
Degree of Vocal Arrests (%) 1.6 (2.8) 3.8 (5.9) 7.3 (10.1) 6.8 0.39 0.68∗∗ 0.49
F0 SD (Hz) 7.3 (10.8) 13.8 (15.2) 16.8 (15.3) 13.1∗∗ 0.20 0.68∗∗∗ 0.51
Recurrence Period Density Entropy 0.60 (0.18) 0.57 (0.16) 0.56 (0.16) 0.52 -0.09 -0.23 -0.13
Jitter (local) (%) 0.73 (0.47) 1.1 (1.7) 1.0 (1.0) 0.70 -0.10 0.32 0.36
Shimmer (local) (%) 8.5 (3.6) 7.9 (4.0) 8.4 (4.5) 0.37 0.14 0.02 0.15
Harmonics to Noise Ratio (dB) 16.1 (4.1) 15.8 (5.2) 15.3 (5.1) 0.52 -0.11 -0.19 -0.07
Detrended Fluctuation Analysis 0.70 (0.04) 0.70 (0.04) 0.68 (0.06) 2.5 -0.52 -0.41 0.16
Frequency Tremor Intensity Index † 4.0 (4.3) 7.1 (6.4) 7.4 (8.1) 3.5 0.07 0.52 0.60
Amplitude Tremor Intensity Index ‡ 24.2 (7.6) 29.4 (14.7) 27.2 (14.4) 13.7∗∗ 0.57 1.10 0.50
Mean of SD of MFCC 6.6 (1.2) 6.6 (0.79) 8.5 (1.7) 25.6∗∗∗ 1.23∗∗∗ 1.21∗∗∗ 0.01
Mean of SD of Delta MFCC 1.3 (0.19) 1.2 (0.25) 1.5 (0.38) 14.7∗∗ 0.80∗∗ 0.77∗∗∗ -0.13
5.2. Individual level: Machine Learning
To assess the performance of each set of features for classifica-
tion and regression, we conducted 100 repeated learning-testing
with 20% of the data left out as test set [29]. We used scikit-
learn for all our models and data processing [30].
5.2.1. Group classification
We first compared the predictive power of the different input
features to discriminate between the three groups: Controls (C),
preHD, and HD patients. To do so, we trained a logistic regres-
sion regularised with ElasticNet (e.g. L1 and L2 combined with
C = 1 and ratio = 0.5). Then, we computed the mean and
standard deviation of the Accuracy and the F1 score (See Table
4). We also reported the chance level by selecting randomly the
class based on the prior distribution.
5.2.2. Regression of the clinical scores
Second, we assessed the predictive capabilities of the features
to predict the composite score cUHDRS [16] (currently used
in international clinical trials [31]), the TFC and the TMS. We
trained a Linear regression model a with ElasticNet regulariser
(e.g. L1 and L2 combined with C = 1 and ratio = 0.5). The
phonation from Controls are not used in the regression. Then,
we computed the mean and standard deviation of the Mean Ab-
solute Error and the coefficient of Determination R2 (See Table
4) as well as the chance level by predicting the mean of each
outcome on the train set.
6. Results and discussions
Statistical Analyses in Table 3 showed that the most affected
dimensions in HD are those related to airflow insufficiency and
articulatory deficiency. We did not find any significant differ-
ence between PreHD and Controls, while both groups differed
from HD. Post-hoc analyses revealed that HD differed from
from Controls but not from preHD for pitch/F0 related features:
the Degree of Pitch Breaks, the Degree of Vocal Arrests, and
Standard deviation of the F0. This suggests an impairment of
the vocal cords control prior to the clinical onset. None of the
Phonatory features were sufficient to distinguish preHD from
Controls. Tremor features displayed the strongest effect size
when comparing preHD and Controls. But the unequal level
of data loss in each group (51% HD, 38% preHD, and 25%
Controls) suggests defining estimation methods that incorporate
tremor instability and better tremor tracking methods [14] for
future work.
The classification results (Table 4) for the Phonatory fea-
tures yielded lower discrimination than the MPS features.
Phonatory features performances are lower than the studies
[4, 10]. This can be explained by the difference in the defi-
nition of the preHD group: the preHD population were based
on a previous definition (the Diagnostic Confidence Level, item
17 of the UHDRS Motor Assessment). Some of their preHD
genetic carrier showed some motor deficits (TMS than was up
to 8 in their population). Besides, these differences may be due
to the small sample size, inter-individual variability. The differ-
ences can also be attributed to the difficulty to tease apart the
3 groups in comparison to 2 groups comparison only. Besides,
the MPS features are more suitable to identify the preHD. We
also show the type of errors made by each set of features with
the Confusion Matrices (see Figure 2). HD are the most iden-
tifiable group. Clearly, the preHD are often confused by the
model as HD or Controls. Yet the types of errors differ. With
the Phonatory features the preHD are even more classified as
Controls than the Controls themselves (0.68 versus 0.45), which
suggests a compensation mechanism.
The weights of the logistic regression trained to classify the
sub-group based on the MPS features are interpretable. These
weights can be visualised in the Figure 1. Even though the
models had no prior how close the features are in the MPS
space, we saw the emergence of patterns. The HD sub-classifier
showed an area of activations for spectral modulation around
4 cycles/kHZ, which can be associated with temporal modula-
Figure 1: Averaged weights of the Logistic Regression regularised with ElasticNet applied on the Modulation Power Spectrum Features
to discriminate between each sub-group. Mean Sparsity = 37.1%
Table 4: Results of the machine learning experiments based on the set of features obtained from the sustain of the vowel /a/. Mean
and Standard Deviation are reported for each metrics. Classification performance is reported with Accuracy and F1-macro score.
Regression performance is reported with the Mean Absolute Error (MAE) and the Coefficient of Determination (R2). Best score for
each metric is reported in bold. † The Phonatory features do not include the tremor features as they could not be computed for each
subject.
Classification Results Regression Results
C vs preHD vs HD cUHDRS TFC TMS
Accuracy F1-macro MAE R2 MAE R2 MAE R2
Random Prior 0.38 (0.1) 0.31 (0.1) 4.21 (0.6) 0.0 (0.0) 1.96 (0.3) 0.0 (0.0) 19.07 (2.3) 0.0 (0.0)
Phonatory feat.† 0.56 (0.1) 0.40 (0.1) 2.78 (0.5) 0.58 (0.2) 1.64 (0.3) 0.37 (0.2) 13.14 (1.7) 0.53 (0.2)
MPS 0.54 (0.1) 0.43 (0.1) 3.68 (0.5) 0.28 (0.1) 1.83 (0.3) 0.15 (0.1) 17.87 (3.2) 0.26 (0.2)
MPS+Phonatory feat.† 0.56 (0.1) 0.46 (0.1) 3.10 (0.5) 0.49 (0.1) 1.70 (0.3) 0.25 (0.1) 15.34 (3.1) 0.29 (0.2)
Figure 2: Confusion matrices for the Logistic regression based
on the Phonatory features (left) and on the MPS features (right)
averaged across all the repeated learning-testing experiments.
tions between -45 and 45 Hz. We found the strongest activation
at the origin (0.0, 0.0), which relates to voice breaks during the
phonation. Even though the classifier is not perfect for preHD,
we saw several specific activations along the Spectral modula-
tion at 2.5 Cycles/kHZ and 7 Cycles/kHZ at Temporal Fre-
quency equal to 0. This might suggest Frequency modulations
specific to preHD, trying to avoid the zone around 4 Cycles/kHz
of HD. The combination of the set of MPS and Phonatory fea-
tures improved the classification performances up to an Accu-
racy of 0.56 and F1-macro of 0.46.
In contrast, Phonatory features better reflected the clinical
scores cUHDRS, TFC, and TMS (Table 4) The composite mea-
sure cUHDRS, currently used in the assessment of international
clinical trial [31], is the best predicted among the scores, if we
rank them based on the coefficient of determination R2. This
means that the Phonatory features are a better indicator of the
severity of the disease, once the clinical onset is declared.
7. Conclusions
Here, we combine the data from three groups for the study
of the vocal markers of sustained phonation in Huntington’s
Disease patients: symptomatic, pre-symptomatic and control.
We applied a statistical analysis, a classification study and as-
sessed the capabilities to predict clinical scores. In addition,
we introduced Modulation Power Spectrum features, in addi-
tion to more traditional Phonatory features. Airflow insuffi-
ciency and articulatory deficiency measures distinguished HD
patients from both preHD and Controls. However, Modulation
Power Spectrum features provided more hope of distinguishing
preHD from Controls. They allowed a three-fold reduction in
mis-identification of preHD. When replicated in a larger scale
and in another population, this suggest that speech phonation
might replace long traditional assessments, considering that the
the sustained vowel task takes less than 1 minute and UHDRS
takes a minimum of 30 minutes when ran by experts. It may
allow repetitive testing with limited retest effect and recordings
could also be blindly scored and analysed. This points to speech
as a major future tool in the clinical panel of assessments.
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Figure 3: Results of the statistical analyses for the Modulation Power Spectrum Features between the three groups for the sustain of the
vowel /a/: Controls (C), asymptomatic genetic carrier of Huntington’s Disease (preHD), symptomatic genetic carrier of Huntington’s
Disease (HD). Left figure is the distribution of the H-statistic. Middle figure is the distribution of the uncorrected p-values. Right figure
is the distribution of the FDR corrected p-values.
10. Appendix
10.1. Additional Statistical analysis for the Modulation
Power Spectrum Features
We tested the differences between groups with the non-
parametric Kruskal-Wallis test. The False-Discovery-Rate cor-
rection is applied to correct for the multiple comparisons (77×
41 = 3157). We reported the statistical results in the Figure
3. 1.7% (14.6%) of the MPS features are found significant
with (without) the FDR correction. We found significant area
to separate the three groups of activation, especially around 4
cycles/kHz (very similar to the area found to identify the symp-
tomatic HD patients).
10.2. Interpretation of coefficients of linear models for the
regression of clinical scores based on the Phonatory features
As we used linear models, each target value is modelled as a lin-
ear combination of the input features. We followed the method-
ology analysis from the example of scikit-learn [30] (link). The
stability of the predictors is shown through the different coef-
ficients across folds. As we used the ElasticNet Regulariser
(L1+L2 regularisation of the coefficients), we also observed
the selection of variables based on the Coefficient Importance
analysis. The results for the regression results for the clinical
measures cUHDRS, TFC, TMS are reported respectively in the
Figure 4, Figure 5, Figure 6.
Figure 4: Coefficient Importance of the different Phonatory
Features across the different cross-validation folds to predict
the cUHDRS
The Maximum Phonation Time and First Occurrence of
Voice Break are the features the most used for all 3 regression
Figure 5: Coefficient Importance of the different Phonatory
Features across the different cross-validation folds to predict
the TFC
Figure 6: Coefficient Importance of the different Phonatory
Features across the different cross-validation folds to predict
the TMS
tasks. The Mean of SD of MFCC also contribute to the pre-
diction of the cUHDRS and TMS. The Detrended Fluctuation
Analysis is also a feature useful for the prediction of the TMS
(coefficient never set to 0).
Otherwise, the contributions of the other features for the
other tasks are more blurred or often set to 0. These coefficient
importance give also the direction associated with the progress
of the scores and then the disease.
